Following the completion of our Vemula plant in 2013 and SQLM in 2016, we plan to continue investing in the latest technology for our facilities, and provide our customers with unwavering product quality. This is demonstrated through our upcoming 2021 product initiatives, which includes elevating our Type I molded glass product portfolio, to provide customers with solutions that meet their individual business and product needs. By making continuous improvements to glass composition, production processes and equipment, and quality criteria, SGD Pharma remains the leader in molded glass packaging.